| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/04/2012 | CN102532262A Preparation of fatty acid-RGD-fatty alcohol conjugate mediated epirubicin targeted liposome and evaluation on anticancer activity |
| 07/04/2012 | CN102532250A Przewalsikone A compound with anti-tumor activity and preparation method and application thereof |
| 07/04/2012 | CN102532246A Oleanolic acid derivative as well as preparation method and application thereof |
| 07/04/2012 | CN102532237A Camptothecin tenth-position cholic acid coupling compound and preparation method thereof |
| 07/04/2012 | CN102532236A Steroid 5Alpha-reductase inhibitors, preparation methods thereof and medical applications thereof |
| 07/04/2012 | CN102532235A Bufogenin derivative and preparation method thereof, composition containing bufogenin derivative and applications thereof |
| 07/04/2012 | CN102532229A Pregnane glycoside compounds with orthoester groups and applications thereof |
| 07/04/2012 | CN102532223A Process for the preparation of 11,12-cyclic erythromycin a carbonate lactobionate and the use thereof |
| 07/04/2012 | CN102532218A Strictosidine-like alkaloid as well as preparation method and application thereof |
| 07/04/2012 | CN102532215A Aminoglycosides antibiotics compound and extraction separation method thereof |
| 07/04/2012 | CN102532211A Lignan triglycoside compound and preparation method and application thereof |
| 07/04/2012 | CN102532210A Glycoside ester compound and preparation method and application thereof |
| 07/04/2012 | CN102532207A N-unsaturated fatty acid acylated chitosan oligosaccharide and preparation and application thereof |
| 07/04/2012 | CN102532199A Structure and synthesis of novel benzyl amido phosphate prodrug of nucleoside compound |
| 07/04/2012 | CN102532198A Antiviral phosphinate compounds |
| 07/04/2012 | CN102532192A Acetaminophen-cyclophosphamide anti-tumor drug and preparation method thereof |
| 07/04/2012 | CN102532180A Boron-containing small molecules |
| 07/04/2012 | CN102532163A Macrocyclic 4-amino-quinazoline derivatives and their use as MTKI |
| 07/04/2012 | CN102532162A 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles |
| 07/04/2012 | CN102532159A Small molecule inhibitors Syntelin for centromere-associated protein E (CENP-E) |
| 07/04/2012 | CN102532156A Swerilactones H-K, 1-4 and medicinal composition and application thereof |
| 07/04/2012 | CN102532154A Angelica oncosepala linear furocoumarins compound and application thereof |
| 07/04/2012 | CN102532153A Lignan compound and application thereof |
| 07/04/2012 | CN102532152A 4'-demethylepipodophyllotoxin compounds and use thereof as anticancer agent |
| 07/04/2012 | CN102532151A 7-ethyl-20(S)-O-substituted benzoyl camptothecin compounds with anticancer activity |
| 07/04/2012 | CN102532150A Alkoxyl dibenzoazepine compound, and preparation method and medical application thereof |
| 07/04/2012 | CN102532148A Compound with anti-tumor effect in zephyranthes candida and separation preparation method and application thereof |
| 07/04/2012 | CN102532144A Novel indoleamine-2,3-dioxygenase inhibitor as well as preparation method and application thereof |
| 07/04/2012 | CN102532141A (1,2,4)-triazolo-(4,3-b) (1,2,4)-triazine compounds, as well as preparation method and use thereof |
| 07/04/2012 | CN102532137A 8-pyrazole substituted xanthine A2B adenosine receptor antagonist and synthesis method and application thereof |
| 07/04/2012 | CN102532135A Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors |
| 07/04/2012 | CN102532134A Azaindoles useful as inhibitors of janus kinases |
| 07/04/2012 | CN102532133A Azaindoles useful as inhibitors of janus kinases |
| 07/04/2012 | CN102532132A Perylene acid addition salt of moxifloxacin |
| 07/04/2012 | CN102532123A Thiazole-5-methanamide compound and preparation method, medicinal composition and application thereof |
| 07/04/2012 | CN102532120A 埃坡霉素(epothilone)，合成埃坡霉素的中间体，其类似物及其用途 Epothilones (epothilone), the synthesis of epothilone intermediates, analogs and their use |
| 07/04/2012 | CN102532118A Indolone-containing 4-thiazolidone derivatives and application thereof |
| 07/04/2012 | CN102532114A Niacin derivative, preparation method thereof and medicine composition thereof |
| 07/04/2012 | CN102532113A Aryl urea derivative |
| 07/04/2012 | CN102532110A Quinazoline derivative and application of serving as cell apoptosis inhibitor |
| 07/04/2012 | CN102532107A 4-substituted aniline-7-substituted alcoxylhomopiperazine-quinazoline derivatives, and preparation method and application thereof |
| 07/04/2012 | CN102532104A Novel aporphinoid compound and preparation method and application thereof |
| 07/04/2012 | CN102532103A Quinazolinyl aryl urea derivatives and preparation method and application thereof |
| 07/04/2012 | CN102532099A Composition, synthesis and application of hydantoin derivatives |
| 07/04/2012 | CN102532092A Natural product Bostrycin derivative I as well as preparation method and application thereof |
| 07/04/2012 | CN102532084A Coumarin compound and preparation method and application thereof |
| 07/04/2012 | CN102532082A 2,2-dimethyl benzopyran compound and preparation method and application thereof |
| 07/04/2012 | CN102532080A Novel sialic acid derivant, preparation method thereof, drug composite comprising the same and application thereof |
| 07/04/2012 | CN102532073A Ethylene derivative serving as selective estrogen receptor modulators (SERMs) |
| 07/04/2012 | CN102532071A L-ascorbyl palmitate particles, and preparation method and application thereof |
| 07/04/2012 | CN102532070A Natural products as retinoic acid receptor (RARs) agonists and application thereof |
| 07/04/2012 | CN102532055A Benzothiazole derivative compounds, compositions and uses |
| 07/04/2012 | CN102532051A 有丝分裂驱动蛋白抑制剂及其使用方法 Mitotic kinesin inhibitors and methods of use |
| 07/04/2012 | CN102532042A Aryl urea compound as well as intermediate and application thereof |
| 07/04/2012 | CN102532039A Application of 5-fluoropyrimidine-4(3H)-ketone compound in preparation of anti-tumor medicaments |
| 07/04/2012 | CN102532037A Novel pyrimidine derivatives as well as preparation method and applications thereof |
| 07/04/2012 | CN102532024A Sinomenine derivative |
| 07/04/2012 | CN102532020A 5, 6, or 7-substituted -3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof |
| 07/04/2012 | CN102532016A 5-aminoquinoline-2(1H) ketone compound and synthetic method and application thereof |
| 07/04/2012 | CN102532009A Compounds for inhibiting dipeptidyl peptidase, preparation method for compounds and application of compounds |
| 07/04/2012 | CN102531999A Amorphous lercanidipine hydrochloride and preparation method thereof |
| 07/04/2012 | CN102531998A Alpha-type polymorphic clevidipine butyrate crystal and preparation method, application and pharmaceutical composition thereof |
| 07/04/2012 | CN102531996A Disubstituted indolone derivative and preparation method and application thereof |
| 07/04/2012 | CN102531995A 3,3'-disubstituted-3-hydroxy bis-indolinone derivative and preparation method and application thereof |
| 07/04/2012 | CN102531966A Novel crystal form D of Retigabine and preparation method thereof |
| 07/04/2012 | CN102531949A Substituted benzamide compounds and preparation method and application thereof |
| 07/04/2012 | CN102531948A 氨基-甲基取代的四环素类化合物 Amino - methyl-substituted tetracycline compounds |
| 07/04/2012 | CN102531946A 3-methoxybenzamide (MBA) derivant as well as preparation method and application thereof |
| 07/04/2012 | CN102531933A Natural product Bostrycin derivates II and preparation method and application thereof |
| 07/04/2012 | CN102531906A Application of natural compound P21 in inhibition of reproductive growth of tumor cell |
| 07/04/2012 | CN102531905A Novel gentisic acid derivatives (2-hydroxy-5-alkyl (H) oxo benzoates) as well as preparation method and new application thereof |
| 07/04/2012 | CN102531902A Caffeoyl tartaric acid, and preparation method and uses thereof |
| 07/04/2012 | CN102531900A Caftaric acid as well as preparation method and applications thereof |
| 07/04/2012 | CN102531893A Shikonin octyl methoxycinnamate derivant as well as synthesis method and application thereof |
| 07/04/2012 | CN102531878A Novel crystal form of sodium valproate, and preparation method and application thereof |
| 07/04/2012 | CN102531868A Anthraquinone derivative, preparation method and application thereof |
| 07/04/2012 | CN102526771A Invisible nano-liposome injection for encapsulating USPIO (Ultra-small Super Paramagnetic Iron Oxide) and preparation method and application thereof |
| 07/04/2012 | CN102526759A Dendritic-polymer-based high-bioavailability oral puerarin preparation |
| 07/04/2012 | CN102526756A Adriamycin composite, micelle and preparation method for micelle |
| 07/04/2012 | CN102526755A Reducibly biodegradable release controlled camptothecin nano micelle pre-medicament and preparation method |
| 07/04/2012 | CN102526752A Bitterness-eliminated medicinal preparation |
| 07/04/2012 | CN102526748A Oral tablet containing valsartan, hydrochlorothiazide and amlodipine besylate |
| 07/04/2012 | CN102526744A Medicinal composition and preparation method and application thereof |
| 07/04/2012 | CN102526741A Composition of arginine and series of cephalosporin acids |
| 07/04/2012 | CN102526740A Novel high-efficiency antiemetic medicinal composition |
| 07/04/2012 | CN102526739A Medicament composition for treating diabetes and application of medicament composition |
| 07/04/2012 | CN102526738A Compound ophthalmic preparation and preparation method as well as application thereof |
| 07/04/2012 | CN102526737A DPP IV inhibitor formulations |
| 07/04/2012 | CN102526736A Treatment of inflammatory diseases |
| 07/04/2012 | CN102526735A Pharmaceutical compositions and method of treating atherosclerosis, dyslipidemias and related conditions |
| 07/04/2012 | CN102526734A Medicine composition for treating age-related hearing loss (ARHL) and application thereof |
| 07/04/2012 | CN102526733A Composition for preventing onset and/or recurrence of cardiovascular events |
| 07/04/2012 | CN102526732A Application of targeted medicine adjusting histone acetylation level in aspect of preparing medicine for preventing or treating autoimmune disease |
| 07/04/2012 | CN102526731A Pharmaceutical composition containing arctigenin |
| 07/04/2012 | CN102526714A Medicine composition for curing tumour and preparation method thereof |
| 07/04/2012 | CN102526701A Cow gender interferon and using method thereof |
| 07/04/2012 | CN102526697A Piracetam cerebroprotein hydrolysate dropping pill and preparation method thereof |
| 07/04/2012 | CN102526691A External application plaster for treating dysmenorrhea |
| 07/04/2012 | CN102526674A Medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven |
| 07/04/2012 | CN102526668A Ginger/white pepper composition for relieving vomiting due to cancer chemotherapy and enhancing effect of cancer chemotherapy and preparation method thereof |